Innovative solutions for the rapid detection of multi drug resistant microorganisms (MDROs) and the smart management and control of antimicrobial resistance (AMR) - Launch of Open Market Consultation.

AVIS DE PRE-INFORMATION

Client : RESAH - Réseau des Acheteurs Hospitaliers

Avis N° : AO-2249-0043

  • 75 - GIP RESAH
  • Services
  • Avis de Pré-information
  • Mise en ligne :

Source : WEB

Lien pour consultation du texte officiel du JOUE :
25/11/2022 S228
France-Paris: Services de santé
2022/S 228-652983
Avis de préinformation
Le présent avis est un avis de préinformation uniquement
Services
Base juridique:
Directive 2014/24/UE
Section I: Pouvoir adjudicateur

I.1) Nom et adresses
Nom officiel: GIP RESAH
Numéro national d'identification: FR61130005010
Adresse postale: 47 rue de Charonne
Ville: PARIS
Code NUTS: FR France
Code postal: 75011
Pays: France
Point(s) de contact: Louis Potel
Courriel:
[email protected]
Téléphone: +33 761735053
Adresse(s) internet:
Adresse principale:
https://www.resah.fr/
Adresse du profil d’acheteur:
https://www.resah.fr/
I.1) Nom et adresses
Nom officiel: Universitá degli Studi di Napoli Federico II, Department of Public Health (UNINA)
Numéro national d'identification: IT00876220633
Adresse postale: via Sergio Pansini, n.5
Ville: Naples
Code NUTS: IT Italia
Code postal: 80131
Pays: Italie
Point(s) de contact: Maddalena Illario
Courriel:
[email protected]
Téléphone: +34 943006250
Adresse(s) internet:
Adresse principale:
http://www.unina.it/
Adresse du profil d’acheteur:
http://www.unina.it/
I.1) Nom et adresses
Nom officiel: Servicio Vasco de Salud Osakidetza (OSAK)
Numéro national d'identification: ESS5100023J
Adresse postale: Calle Alava 45
Ville: Vitoria-Gateiz
Code NUTS: ES España
Code postal: 01006
Pays: Espagne
Point(s) de contact: MARIAISABEL ARZAMENDISESE
Courriel:
[email protected]
Adresse(s) internet:
Adresse principale:
http://www.osakidetza.euskadi.eus/
Adresse du profil d’acheteur:
http://www.osakidetza.euskadi.eus/
I.1) Nom et adresses
Nom officiel: INSTITUT CATALA D'ONCOLOGIA (ICO)
Numéro national d'identification: ESQ5856383D
Adresse postale: Av. Gran Via de l’Hospitalet
Ville: Barcelona
Code NUTS: ES España
Code postal: ES511
Pays: Espagne
Point(s) de contact: Louis Potel
Courriel:
[email protected]
Téléphone: +33 761735053
Adresse(s) internet:
Adresse principale:
https://www.resah.fr/
Adresse du profil d’acheteur:
https://www.resah.fr/


I.2) Informations sur la passation conjointe de marchés
Le marché fait l'objet d'une procédure conjointe
En cas de procédure conjointe impliquant différents pays, législation nationale applicable relative aux marchés:
Cross-border collaborative procurement between French, Spanish and Italian organisations (see explication in section II.2.14)
I.3) Communication
Les documents du marché sont disponibles gratuitement en accès direct non restreint et complet, à l'adresse: https://radar-ppi.com/
Adresse à laquelle des informations complémentaires peuvent être obtenues: le ou les point(s) de contact susmentionné(s)
I.4) Type de pouvoir adjudicateur
Organisme de droit public
I.5) Activité principale
Santé
Section II: Objet
II.1) Étendue du marché
II.1.1) Intitulé:
Innovative solutions for the rapid detection of multi drug resistant microorganisms (MDROs) and the smart management and control of antimicrobial resistance (AMR) - Launch of Open Market Consultation
Numéro de référence: Grant agreement 101036228
II.1.2) Code CPV principal
85100000 Services de santé - RC05
II.1.3) Type de marché
Services
II.1.4) Description succincte:
The four healthcare buyers of the RaDAR PPI project have identified an unmet need for rapid detection of multi-drug resistant microorganisms (MDROs) and smart antimicrobial resistance (AMR) management and control systems to combat a serious and growing global problem. It is anticipated that these buyers will launch coordinated tenders for the procurement of innovative solutions to address this challenge in Q3 of 2023.This prior information notice has been published to provide early notification that a public procurement of innovation will take place and to launch a period of Open Market Consultation (OMC).The second stage involves five Open Market Consultation events: These events will be in person and online and you are invited to register for these events via the market response form which can be found at : https://radar-ppi.com/procurement/


II.1.5) Valeur totale estimée
II.1.6) Information sur les lots
Ce marché est divisé en lots: non
II.2) Description
II.2.3) Lieu d'exécution
Code NUTS: ES España
Code NUTS: FR France
Code NUTS: IT Italia
Lieu principal d'exécution:
Resah : FR France
UNINA: ITF3 Campania region
Osak: ES211 Araba
ICO: ES51 for Cataluña region
II.2.4) Description des prestations:
Hospitals and healthcare units are at the frontline of the battle to detect, manage and control antimicrobial resistance (AMR) among patients and in the clinical environment. While investment in the development of new antibiotics is crucial, another important area where innovation is needed is the rapid detection, management, and control of AMR.
RaDAR aims to address this urgent need for rapid detection and effective infection control systems for AMR, through a public procurement of innovation (PPI). The four healthcare buyers have identified an unmet need for rapid detection of multi-drug resistant microorganisms (MDROs) and antimicrobial resistance management and control systems to combat this serious and growing global problem.
The procurement will be carried out in a collaborative manner by them, GIP Resah will act as lead procurer. The RaDAR PPI buyers' group is composed of: GIP Resah (France), Institut Catala d’Oncologia (Spain),Servicio Vasco de Salud Osakidetza (Spain), Universitá degli Studi di Napoli Federico II, Department of Public Health (Italy). These buyers will launch coordinated tenders for the procurement of innovative solutions to address this challenge in Q3 of 2023. A prior information notice has been published to provide early notification that a public procurement of innovation will take place and that a period of Open Market Consultation (OMC) is going to be launched. The first stage of the OMC is a market sounding : Interested parties are invited to read the market Sounding Prospectus (MSP) and provide feedback via the Market Response Form: https://radar-ppi.com/procurement/
The second stage involves five Open Market Consultation events: these events will be in person and online and you are invited to register for these events via the market response form which can be found at: https://radar-ppi.com/procurement/.
A direct link to the response form can be found at RaDAR Market Response Form
Based on the conclusions of the second stage, a potential third stage of the OMC will be opened to perform bilateral meetings between public buyers and economic operators. In that case, interested parties, market actors and innovation agents will be invited to have bilateral meetings with public buyers after the Open Market Consultation events. Any update on this behalf will be provided in the website https://radar-ppi.com/procurement/
The aim of this open market consultation is to open a dialogue with the supply chain to: Explore what solutions are or could be available given the right market conditions to address the unmet needs and requirements identified by the buyers group (see section 3), Understand the timeframes over which these solutions can be mobilised or become available, Inform the buyers group as to how we can support suppliers and innovators to deliver innovative solutions to meet these needs. The buyers and their expert partners have conducted an initial state of the art review and believe that the supply chain has the information, insights and creativity to address the challenges outlined in the MSP, and are open to all ideas, from all parts of the supply chain, that could contribute to addressing this important challenge area.The feedback from the supply chain will be used to refine the clinical demand of the four buyers and inform the collaborative tender specification and strategy. RaDAR Buyers will conduct a cross-border collaborative procurement of innovation : that each buyer will publish their own call for tenders in their country (1 in France, 1 in Italy and 2 in Spain). 1Common preparatory phase - Buyers worked collaboratively on common needs identification, and are launching this common open market consultation; 2Coordinated publication – Buyers will work on coordinated individual tenders’ preparation per locality so that each buyer procures according to their context and national laws and informed by the outcomes of the OMC.3Coordinated evaluation and awarding of the contract.
II.2.14) Informations complémentaires
The second stage involves five Open Market Consultation events: These events will be in person and online and you are invited to register for these events via the market response form which can be found at: https://radar-ppi.com/procurement/.
A direct link to the response form can be found at RaDAR Market Response Form
II.3) Date prévue pour le lancement de la procédure de passation:
22/11/2022

Section IV: Procédure
IV.1) Description
IV.1.8) Information concernant l’accord sur les marchés publics (AMP)
Le marché est couvert par l'accord sur les marchés publics: oui
Section VI: Renseignements complémentaires
VI.3) Informations complémentaires:
Hospitals and specialist healthcare units are at the frontline of the battle to detect, manage and control antimicrobial resistance (AMR) among patients and in their clinical environment. While investment in the development of new antibiotics is crucial, another important area where innovation is needed is the rapid detection, management, and control of AMR in the healthcare environment.
RaDAR aims to address this urgent need for rapid detection and effective infection control systems for AMR, through a public procurement of innovation (PPI). Four healthcare buyers have identified an unmet need for rapid detection of multi-drug resistant microorganisms (MDROs) and antimicrobial resistance management and control systems to combat this serious and growing global problem.
The procurement will be carried out in a collaborative manner by the organisations of the buyers' group, GIP Réseau des acheteurs hospitaliers (Resah) will act as lead procurer.
As of the date of the publication of this information notice the RaDAR PPI buyers' group is composed of:
- GIP Resah (France)
- Institut Catala d’Oncologia (Spain)
- Servicio Vasco de Salud Osakidetza (Spain)
- Universitá degli Studi di Napoli Federico II, Department of Public Health (Italy)
It is anticipated that these buyers will launch coordinated tenders for the procurement of innovative solutions to address this challenge in Q3 of 2023.
This prior information notice has been published to provide early notification that a public procurement of innovation will take place and that a period of Open Market Consultation (OMC) is going to be launched.
The first stage of the OMC is a market sounding: Interested parties, market actors and innovation agents are invited to read the market Sounding Prospectus (MSP) and provide feedback via the Market Response Form: https://radar-ppi.com/procurement/
The second stage involves five Open Market Consultation events: These events will be in person and online and you are invited to register for these events via the market response form which can be found at: https://radar-ppi.com/procurement/.
A direct link to the response form can be found at RaDAR Market Response Form
Based on the conclusions of the second stage, a potential third stage of the OMC will be opened to perform bilateral meetings between public buyers and economic operators. In that case, interested parties, market actors and innovation agents will be invited to have bilateral meetings with public buyers after the Open Market Consultation events. Any update on this behalf will be provided in the website https://radar-ppi.com/procurement/
The aim of this open market consultation is to open a dialogue with the supply chain to:
- Explore what solutions are or could be available given the right market conditions to address the unmet needs and requirements identified by the buyers group (see section 3) Understand the timeframes over which these solutions can be mobilised or become available
- Inform the buyers group as to how we can support suppliers and innovators to deliver innovative solutions to meet these needs.
The buyers and their expert partners have conducted an initial state of the art review and believe that the supply chain has the information, insights and creativity to address the challenges outlined in the MSP, and are open to all ideas, from all parts of the supply chain, that could contribute to addressing this important challenge area.
The feedback from the supply chain will be used to refine the clinical demand of the four buyers and inform the collaborative tender specification and strategy.
RaDAR Buyers Group will conduct a cross-border collaborative procurement of innovation, which means that each buyer will publish their own call for tenders in their country (1 call in France, 1 call in Italy and 2 calls in Spain).
VI.5) Date d’envoi du présent avis:
21/11/2022

Envoyer à un contact

Identification

Vous souhaitez envoyer cet avis à un contact ?

Renseignez simplement les noms et adresses mail de vos destinataires

NOM DU DESTINATAIRE *

1
2
3
4
5

MAIL DU DESTINATAIRE *

* Champs obligatoires

Vous pouvez personnaliser votre message